MIAO Jiu-wang, ZHANG Qin-de, WANG Hong-bo, et al. Bisdemethoxycurcumin Induced Human Leukemia K562 Cells Apoptosis Through Down-regulation of Mitochondrial Membrane Potential[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(24): 109-113.
MIAO Jiu-wang, ZHANG Qin-de, WANG Hong-bo, et al. Bisdemethoxycurcumin Induced Human Leukemia K562 Cells Apoptosis Through Down-regulation of Mitochondrial Membrane Potential[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(24): 109-113. DOI: 10.13422/j.cnki.syfjx.2015240109.
Objective: To explore the antitumor effects and mechanisms of bisdemethoxycurcumin(BDMC) on K562 cells. Method: K562 cells were treated with 1
10
30
50
100μmol·L-1 of BDMC for 48 h or 72 h
then the anti-proliferative effect was assessed by MTT assay.K562 cells were treated with 10
30
50μmol·L-1 of BDMC for 24 h or 48 h
and another blank group was also established. The apoptosis morphology was observed by AO/EB staining using fluorescence microscope
mitochondrial membrane potential(MMP) was detected by Rhodamine 123 staining using flow cytometry instrument and apoptosis rate was detected by Annexin V/PI staining using flow cytometry instrument. The expression of Bcl-2
Bax was evaluated by Western blot method. Result: BDMC could inhibit the proliferation of K562 cells in a dose dependent manner when compared with the blank group. BDMC at the dose of 30
50μmol·L-1 could induce cell apoptosis
decrease the ratio of Bcl-2/Bax and reduce mitochondrial membrane potential. Conclusion: BDMC could inhibit proliferation of K562 cells
and its mechanism may be related with the induction of cell apoptosis via mitochondria pathway.